Pharmaceutical Companies

This strategic approach aligns with President Bola Tinubu’s broader vision to unlock the healthcare value chain by empowering local pharmaceutical industries.

The new generic formulation matches the composition of Celgene’s original Pomalyst medication and comes in four different strengths: 1mg, 2mg, 3mg, and 4mg.

The new manufacturing hub represents a core strategic priority for PharmaEssentia as the company works to strengthen its supply chain, increase production flexibility, and diversify its geographic footprint.

The Japanese pharmaceutical giant expects the transaction to conclude during the first quarter of fiscal 2026, subject to standard regulatory conditions.

The EMA will now proceed with a final decision, potentially clearing the way for global distribution of this combination immunization.

The tabletting facility in Athlone represents a cornerstone of Novo Nordisk’s long-term strategy to strengthen its presence in Ireland and enhance its global manufacturing footprint.

The agreement grants Novo Nordisk licensing rights to select oral drug-delivery technologies from Vivtex.

This initiative directly supports Oman Vision 2040, the national strategic framework that prioritizes industrial diversification and self-sufficiency in essential sectors.

AbbVie plans to hire 300 new employees for the facilities, targeting engineers, scientists, manufacturing operators, and lab technicians in the North Chicago area.